Comparison of hysteroscopic and hysterectomy findings to assess the diagnostic accuracy of office hysteroscopy in tamoxifen-treated patients with breast cancer

被引:10
|
作者
Ceci, O [1 ]
Bettocchi, S [1 ]
Nappi, L [1 ]
Di Venere, R [1 ]
Pansini, MV [1 ]
Di Fazio, F [1 ]
机构
[1] Univ Bari, Policlin, Sez Ostetricia & Ginecol, Dept Gen & Specialty Surg Sci, I-70124 Bari, Italy
关键词
D O I
10.1016/S1074-3804(05)60270-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Study Objective. To assess the diagnostic accuracy of office hysteroscopy by comparing hysteroscopic findings with histologic findings on hysterectomy specimens in postmenopausal women with breast cancer treated with tamoxifen. Design. Retrospective clinical study (Canadian Task Force classification 11-2). Setting. University-affiliated hospital. Patients. Thirty-three women. Intervention. Record review. Measurements and Main Results. Compared with histologic diagnoses of uteri, hysteroscopic findings showed diagnostic sensitivity of 97%, specificity of 100%, positive predictive value of 100% and negative predictive value of 96%. The diagnostic accuracy of hysteroscopy is the same in patients taking tamoxifen as in the general population. Conclusion. Hysteroscopy is a powerful method for diagnosing endometrial disease because it provides a direct view of the uterine cavity, reveals focal lesions, and enables targeted biopsies to be performed at the same time.
引用
收藏
页码:392 / 395
页数:4
相关论文
共 50 条
  • [41] Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status
    Simonsson, Maria
    Soderlind, Viktoria
    Henningson, Maria
    Hjertberg, Maria
    Rose, Carsten
    Ingvar, Christian
    Jernstrom, Helena
    CANCER CAUSES & CONTROL, 2013, 24 (05) : 929 - 940
  • [42] Does ER-βcx Really Have No Clinical Importance in Tamoxifen-Treated Breast Cancer Patients?
    Palmieri, Carlo
    Gojis, Ondrej
    Rudraraju, Bharath
    Cleator, Susan
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (35) : 5824 - 5824
  • [43] Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status
    Maria Simonsson
    Viktoria Söderlind
    Maria Henningson
    Maria Hjertberg
    Carsten Rose
    Christian Ingvar
    Helena Jernström
    Cancer Causes & Control, 2013, 24 : 929 - 940
  • [44] Ovarian cysts in postmenopausal tamoxifen-treated breast cancer patients with endometrial thickening detected by transvaginal sonography
    Kazandi, M
    Sendag, F
    Akercan, F
    Terek, MC
    Ozsaran, A
    Dikmen, Y
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2002, 23 (03) : 257 - 260
  • [46] The prognostic importance of various clinical, pathological, and immunohistochemical parameters in tamoxifen-treated patients with early breast cancer
    Mermershtain, W.
    Lazarev, I.
    Geffen, D. B.
    Grinberg, V.
    Ariad, S.
    EJC SUPPLEMENTS, 2009, 7 (02): : 305 - 306
  • [47] The value of transvaginal ultrasonography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients
    Markovitch, O
    Tepper, R
    Fishman, A
    Shapira, J
    Aviram, R
    Cohen, I
    GYNECOLOGIC ONCOLOGY, 2004, 95 (03) : 456 - 462
  • [48] Amplified in breast cancer 1 in human epidermal growth factor receptor-positive tumors of tamoxifen-treated breast cancer patients
    Kirkegaard, Tove
    McGlynn, Liane M.
    Campbell, Fiona M.
    Mueller, Sven
    Tovey, Sian M.
    Dunne, Barbara
    Nielsen, Kirsten V.
    Cooke, Timothy G.
    Bartlett, John M. S.
    CLINICAL CANCER RESEARCH, 2007, 13 (05) : 1405 - 1411
  • [49] Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints - a prospective observational study
    Rostock, Matthias
    Fischer, Julia
    Mumm, Andreas
    Stammwitz, Ute
    Saller, Reinhard
    Bartsch, Hans Helge
    GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (10) : 844 - 848
  • [50] The predictive value of Her2/neu status on clinical outcome in tamoxifen-treated breast cancer patients
    Hanna, W
    Wong, JW
    Zubovits, J
    Trudeau, M
    LABORATORY INVESTIGATION, 2003, 83 (01) : 32A - 32A